Previous 10 | Next 10 |
home / stock / elv / elv articles
Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $...
Morgan Stanley has initiated coverage on Elevance Health Inc (NYSE:ELV), an American health insurance provider formerly Anthem Inc, citing compelli...
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 6.3% on an annualized basis producing an average annual return of ...
U.S. stocks were mixed, with the Nasdaq Composite falling around 1% on Friday. Shares of Ambarella, Inc. (NASDAQ:AMBA) rose sharply during Friday...
Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years by 5.0% on an annualized basis producing an average annual return of ...
UnitedHealth Group Inc. (NYSE:UNH) saw its shares decline significantly Wednesday afternoon following remarks made by CEO Andrew Witty at the Berns...
Elevance Health (NYSE:ELV) has outperformed the market over the past 5 years by 3.78% on an annualized basis producing an average annual return of ...
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in t...
These seven large-cap stocks were the best performers in the last week. Are they in your portfolio? United Airlines Holdings, Inc. (NASDAQ:UA...
News, Short Squeeze, Breakout and More Instantly...
Elevance Health Inc Com Company Name:
ELV Stock Symbol:
NYSE Market:
Elevance Health Inc Com Website:
2024-07-17 12:00:27 ET Image source: The Motley Fool. Elevance Health (NYSE: ELV) Q2 2024 Earnings Call Jul 17, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Elevance Health (ELV) Q2 2024 Earnings Call Transcript
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...